In the current study, we have demonstrated that anethole inhibits the epithelial-to-mesenchymal transition in oral cancer through blocking migration/invasion abilities of cells and suppressing the EMT via the enhancement of the epithelial marker E-cadherin, attenuating the prominent mesenchymal marker (vimentin) and reducing the MMPs secretion. This evidence concerns the gene VIM and lip and oral cavity carcinoma.